Stock OXYGEN BIOTHERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Oxygen Biotherapeutics, Inc. Nasdaq

Equities

US69207P2092

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Oxygen Biotherapeutics, Inc.
May. 14 Tenax Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 28 Tenax Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Chart calendar Oxygen Biotherapeutics, Inc.

072fffac6f19210a03822.NBY5FqF9hc0t8WacU5guxEV2YypFd8lfceHUrWwpkls.BGBKUO4I8_xPklDrBfxxiRIuDW8vAqoxOK2z6h4EqjpVYV4m5g289HK_Ug~71d0f3dfbc4b05c940649d1ae893cc84

Upcoming events on Oxygen Biotherapeutics, Inc.

2024-08-18 Q2 2024 Earnings Release (Projected)
2025-03-26 Q4 2024 Earnings Release (Projected)
2025-05-19 Q1 2025 Earnings Release (Projected)
2026-03-25 Q4 2025 Earnings Release (Projected)

Past events on Oxygen Biotherapeutics, Inc.

2024-06-07 09:00 am Annual General Meeting
2024-05-14 08:00 am Q1 2024 Earnings Release
2024-04-18 10:00 am Investor Meeting - Key Opinion Leader
2024-03-28 08:30 am Q4 2023 Earnings Release
2024-03-18 06:00 pm ROTH Conference
2024-03-06 09:39 am Technology and Heart Failure Therapeutics Conference
2024-01-02 Reverse Split: 1 of 80
2023-11-29 Extraordinary Shareholders Meeting
2023-01-04 Reverse Split: 1 of 20
2022-04-01 American College of Cardiology Meeting
2022-03-31 08:30 am FY 2021 Earnings Release
2022-01-04 LifeSci Partners Corporate Access Event
2021-11-16 08:30 am Q3 2021 Earnings Release
2021-09-29 01:35 pm Benziga Healthcare Small Cap Conference
2021-09-13 07:00 am H.C. Wainwright Global Investment Conference
2021-08-17 08:00 am Interim 2021 Earnings Release
2021-08-16 10:00 am Investor Meeting - Key Opinion Leader
2021-06-09 Annual General Meeting
2021-05-17 05:15 pm Q1 2021 Earnings Release
2021-03-31 04:45 pm FY 2020 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		-9,86
-8,90
-10.83%		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-8,56
-8,25
-3.7%		-9,87
-8,90
-10.88%		-32,7
-33,6
2.45%		-11,1
-12,0
7.92%		-8,23
-7,39
-11.47%
-19,4

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-8,39
-8,40
0.07%		-9,85
-8,90
-10.69%		-32,5
-33,5
2.92%		-11,0
-12,0
7.96%		-7,71
-7,18
-7.35%
-19,3

Net income
Million USD		Released
Forecast
Spread 		-8,39
-11,9
29.16%		-9,85
-8,90
-10.69%		-32,5
-33,5
2.92%		-11,0
-12,0
7.96%		-7,71
-7,18
-7.35%
-19,3

EPS
USD		Released
Forecast
Spread 		-2 160
-2 488
13.18%		-2 128
-1 352
-57.4%		-2 528
-2 600
2.77%		-601
-745
19.33%		-31,0
-28,8
-7.78%
-8,18

Announcement Date30/03/2031/03/2129/03/2231/03/2328/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread


-2,86
-2,50
-14.48%		-2,92
-3,25
10.23%		-2,55
-3,50
27.09%		-1,54
-2,63
41.53%		-1,24
-2,07
40.15%		-2,12
-2,60
18.56%		-3,34
-2,49
-34.15%		-3,91
-3,51
-11.44%
-4,47


-5,14


-5,93

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread


-2,86
-2,50
-14.44%		-2,92
-3,25
10.26%		-2,55
-3,50
27.25%		-1,41
-2,63
46.57%		-1,11
-2,07
46.44%		-1,97
-2,60
24.15%		-3,23
-2,49
-29.52%		-3,80
-3,51
-8.32%
-4,47


-5,14


-5,93

Net income
Million USD		Released
Forecast
Spread 		-2,72


-2,86
-2,50
-14.44%		-2,92
-3,25
10.26%		-2,55
-3,50
27.25%		-1,41
-2,63
46.57%		-1,11
-2,07
46.44%		-1,97
-2,60
24.15%		-3,23
-2,49
-29.52%		-3,80
-3,51
-8.32%
-4,47


-5,14


-5,93

EPS
USD		Released
Forecast
Spread 		-176


-176
-144
-22.22%		-176
-168
-4.76%		-72,8
-212
65.73%		-12,0
-29,6
59.46%		-4,00
-8,00
50%		-6,40
-9,60
33.33%		-8,64
-8,15
-6.08%		-3,12
-2,40
-30%
-2,25


-2,47


-1,42

Announcement Date16/05/2211/08/2210/11/2231/03/2315/05/2314/08/2313/11/2328/03/2414/05/24---

Upcoming sector events for Oxygen Biotherapeutics, Inc.

2024-07-15 01:45 am ADDLIFE AB: Q2 2024 Earnings Release
2024-07-21 MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-23 SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-23 ALKERMES PLC: Q2 2024 Earnings Release (Projected)
2024-07-23 IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected)
2024-07-23 ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected)
2024-07-24 LONZA GROUP AG: Q2 2024 Earnings Release
2024-07-25 01:00 am BACHEM HOLDING AG: Q2 2024 Earnings Release
2024-07-25 PHARVARIS N.V.: Q2 2024 Earnings Release (Projected)
2024-07-26 01:00 am BB BIOTECH AG: Q2 2024 Earnings Release
More events

Past sector events for Oxygen Biotherapeutics, Inc.

2024-06-07 02:57 am POLARIS GROUP: May 2024 Sales and Revenue Release
2024-05-29 04:01 pm IMMUNOVANT, INC.: Q4 2024 Earnings Release
2024-05-23 07:00 am CUREVAC N.V.: Q1 2024 Earnings Release
2024-05-22 01:00 am EVOTEC SE: Q1 2024 Earnings Release
2024-05-21 05:14 pm ALVOTECH: Q1 2024 Earnings Release
2024-05-21 07:00 am EXSCIENTIA PLC: Q1 2024 Earnings Release
2024-05-17 02:00 am BIOARCTIC AB: Q1 2024 Earnings Release
2024-05-15 04:05 pm CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-15 07:00 am PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 GNI GROUP LTD.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. TENX Stock
  4. Stock
  5. Calendar Oxygen Biotherapeutics, Inc.